Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00484_DB00601_nanopub.RA5qpjfhtti3p4vOHG7xJRlOa-vNgyEvYZjTHRUD2aGQ8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00484_DB00601 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00484_DB00601 label "DDI between Brimonidine and Linezolid - MAO Inhibitors like linezolid may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated. [drugbank_resource:DB00484_DB00601]" assertion.
- drugbank_resource:DB00484_DB00601 identifier "drugbank_resource:DB00484_DB00601" assertion.
- drugbank_resource:DB00484_DB00601 title "DDI between Brimonidine and Linezolid - MAO Inhibitors like linezolid may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated." assertion.
- drugbank:DB00484 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB00601 assertion.
- drugbank:DB00601 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB00601 assertion.